5-[(3E,5Z)-hepta-1,3,5-trien-4-yl]-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one

C28H26F3N7O3 — CID 176704444

IUPAC5-[(3E,5Z)-hepta-1,3,5-trien-4-yl]-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one
SMILESC=C/C=C(\C=C/C)C1=NC(Nc2nnc(-c3ncc(C(F)(F)F)cc3N3CCOCC3)o2)C(=O)Nc2ccccc21
InChIInChI=1S/C28H26F3N7O3/c1-3-7-17(8-4-2)22-19-9-5-6-10-20(19)33-25(39)24(34-22)35-27-37-36-26(41-27)23-21(38-11-13-40-14-12-38)15-18(16-32-23)28(29,30)31/h3-10,15-16,24H,1,11-14H2,2H3,(H,33,39)(H,35,37)/b8-4-,17-7+
InChIKeyKNICTHXFNBXKAU-JTZMYGOQSA-N
MW565.56 g/mol
LogP4.85
Rot. Bonds7

About 5-[(3E,5Z)-hepta-1,3,5-trien-4-yl]-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one

5-[(3E,5Z)-hepta-1,3,5-trien-4-yl]-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one (PubChem CID 176704444) has the molecular formula C28H26F3N7O3 and a molecular weight of 565.56 g/mol. Its IUPAC name is 5-[(3E,5Z)-hepta-1,3,5-trien-4-yl]-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one.

Molecular Properties

Compound Name5-[(3E,5Z)-hepta-1,3,5-trien-4-yl]-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one
PubChem CID176704444
Molecular FormulaC28H26F3N7O3
Molecular Weight565.56 g/mol
Exact Mass565.20
IUPAC Name5-[(3E,5Z)-hepta-1,3,5-trien-4-yl]-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one
SMILESC=C/C=C(\C=C/C)C1=NC(Nc2nnc(-c3ncc(C(F)(F)F)cc3N3CCOCC3)o2)C(=O)Nc2ccccc21
InChIInChI=1S/C28H26F3N7O3/c1-3-7-17(8-4-2)22-19-9-5-6-10-20(19)33-25(39)24(34-22)35-27-37-36-26(41-27)23-21(38-11-13-40-14-12-38)15-18(16-32-23)28(29,30)31/h3-10,15-16,24H,1,11-14H2,2H3,(H,33,39)(H,35,37)/b8-4-,17-7+
InChIKeyKNICTHXFNBXKAU-JTZMYGOQSA-N
XLogP4.85
TPSA117.77 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds7
Heavy Atoms41
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500565.56
LogP ≤ 54.85
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'polyene', 'substructure': 'N/A'}

Analyze 5-[(3E,5Z)-hepta-1,3,5-trien-4-yl]-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[(3E,5Z)-hepta-1,3,5-trien-4-yl]-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one?
The IUPAC name of 5-[(3E,5Z)-hepta-1,3,5-trien-4-yl]-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one (CID 176704444) is 5-[(3E,5Z)-hepta-1,3,5-trien-4-yl]-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one.
What is the SMILES notation for 5-[(3E,5Z)-hepta-1,3,5-trien-4-yl]-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one?
The canonical SMILES for 5-[(3E,5Z)-hepta-1,3,5-trien-4-yl]-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one is C=C/C=C(\C=C/C)C1=NC(Nc2nnc(-c3ncc(C(F)(F)F)cc3N3CCOCC3)o2)C(=O)Nc2ccccc21.
What is the InChIKey of 5-[(3E,5Z)-hepta-1,3,5-trien-4-yl]-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one?
The InChIKey is KNICTHXFNBXKAU-JTZMYGOQSA-N. The full InChI is InChI=1S/C28H26F3N7O3/c1-3-7-17(8-4-2)22-19-9-5-6-10-20(19)33-25(39)24(34-22)35-27-37-36-26(41-27)23-21(38-11-13-40-14-12-38)15-18(16-32-23)28(29,30)31/h3-10,15-16,24H,1,11-14H2,2H3,(H,33,39)(H,35,37)/b8-4-,17-7+.
What are the key properties of 5-[(3E,5Z)-hepta-1,3,5-trien-4-yl]-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one?
5-[(3E,5Z)-hepta-1,3,5-trien-4-yl]-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one has a molecular weight of 565.56 g/mol, XLogP of 4.85, 7 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[(3E,5Z)-hepta-1,3,5-trien-4-yl]-3-[[5-[3-morpholin-4-yl-5-(trifluoromethyl)-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one is sourced from PubChem (CID 176704444), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).